Claudio G Brunstein

11PUBLICATIONS
41CO-AUTHORS
Gene and molecular therapyRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 09, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment Trial.

|Sep 18, 2025
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation.

Stephanie J Lee, Brent Logan, Mary M Horowitz

|Aug 01, 2025
Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudil.

Victoria Stepanyants, Hong Li, Danielle Cenin

|May 01, 2025
Health Care, Physics, and Finance: The Complex Equation of Outpatient CAR T-Cell Therapy.

Joseph M Farinella, Claudio G Brunstein

|Apr 02, 2025
Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantation.

D P Nurse, H Li, D Cenin

|Jun 23, 2023
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.

Betty K Hamilton, Lisa A Rybicki, Hong Li

Pageof 2

Frequent Collaborators

4 joint publications

Daniel J Weisdorf

3 joint publications

Najla El Jurdi

3 joint publications

Grigori Okoev

3 joint publications

Betty K Hamilton